Chase Sun Pharmaceuticals released its performance for the first half of the year, with a net profit attributable to the parent company of 78.63 million yuan, a decrease of 46.95%

According to the Zhitong Finance APP, Chase Sun (300026.SZ) released its semi-annual report for 2025, showing an operating income of 2.795 billion yuan, a year-on-year decrease of 6.72%. The net profit attributable to shareholders of the listed company was 78.63 million yuan, a year-on-year decrease of 46.95%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 69.1796 million yuan, a year-on-year decrease of 49.53%. The basic earnings per share were 0.03 yuan